5-Methyl-2-(1-methylbutyl)-5-propyl-1,3-dioxane
Common Name: |
5-Methyl-2-(1-methylbutyl)-5-propyl-1,3-dioxane |
IUPAC Name: |
5-methyl-2-pentan-2-yl-5-propyl-1,3-dioxane |
Molecular Formula: |
C13H26O2 |
SMILES: |
CCCC(C)C1OCC(CO1)(C)CCC |
Inchi: |
1S/C13H26O2/c1-5-7-11(3)12-14-9-13(4,8-6-2)10-15-12/h11-12H,5-10H2,1-4H3 |
Inchi Key: |
LODLFUCEWWWXPR-UHFFFAOYSA-N |
Cas No: |
80480-24-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
214.34 |
Mass (g/mol) |
214.193 |
Molar Refractivity |
64.40 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
15 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
72.00 @ 0.10 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.034 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
3.602 |
iLOGP |
3.44 |
XLOGP3 |
4.19 |
WLOGP |
3.60 |
MLOGP |
2.77 |
ESOL Log S |
-3.48 |
ESOL Solubility (mg/ml) |
0.071 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.29 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.45 |
Silicos-IT Solubility (mg/ml) |
0.08 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.63 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.864 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.658 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |